Ocular Therapeutix, Inc. (OCUL)
9.495
+0.26
(+2.76%)
USD |
NASDAQ |
May 14, 16:00
9.47
-0.02
(-0.26%)
After-Hours: 19:55
Ocular Therapeutix Shareholders Equity (Quarterly) : 581.57M for March 31, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| EyePoint, Inc. | 230.47M |
| Merck & Co., Inc. | 45.88B |
| Zevra Therapeutics, Inc. | 205.80M |
| Axsome Therapeutics, Inc. | 54.59M |
| Bristol Myers Squibb Co. | 20.07B |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 732.53M |
| Total Liabilities (Quarterly) | 150.96M |
| Debt to Equity Ratio | 0.1366 |
| Current Ratio | 14.81 |
| Net Debt Paydown Yield | -0.04% |